Meta Pixel
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

News and Announcements

QBiotics Channel 7 News Feature: Scientists Find Australian Berry to Cure Cancer

  • Published August 16, 2016 9:25AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

15th August 2016, 7 News

A berry found on Australia’s Blushwood tree in the far north is believed to cure many types of cancer. Scientists made the breakthrough with EBC46 making tumours disappear in just 48 hours.

ABOUT QBIOTICS LIMITED

QBiotics Limited is developing a pipeline of promising drugs in the area of cancer and wound healing. Its lead drug, EBC-46, targets solid tumours and is currently in late pre-clinical development in preparation for a Human Clinical Phase I/II trial with the USA’s FDA. EBC-46 is also in late stage development for the veterinary market through the USA’s FDA-CVM.

Capital Insights
Trillion-Dollar Investment Convergence: Life Sciences, AI & Energy

Discover trillion-dollar investment opportunities at the intersection of Life Sciences, AI, and Energy Transition. This article explores why sophisticated investors are flocking to these sectors, driven by massive markets, government backing, and technological maturity. Learn what to expect at Venture & Capital Sydney 2025, where innovation meets strategic capital for the next decade of wealth creation.

Company Updates
Steve Torso on Why Brevity Wins in Capital Raising

In the relentless pursuit of investment, founders often believe more information equates to more persuasion. However, according to Steve Torso, Co-founder and Managing Director at CapitalHQ and Wholesale Investor, the science of successful capital raising dictates a counter-intuitive approach: less is more, especially in the initial stages. “When you’re actually communicating your business, you’ve got […]

Capital Insights
Beyond the Balance Sheet: Building for a Strategic Premium in Your Business Exit

To achieve an exceptional business exit, focusing solely on financials isn’t enough. This article explores how to build a “strategic premium” by positioning your business as an indispensable asset for specific acquirers. Learn what strategic buyers truly seek, how to build this value before you sell, and how to craft a compelling narrative that secures higher valuations and better deal terms.

Join over 45,000+ sophisticated investors

Join Now